Close
ACHEMA MIDDLE EAST 2026

ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability

In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive...

GSK Unveils Its Transformation Through New Branding And Logo

The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and...

Vazkepa From Amarin Gets Recommended By NICE In The U.K

Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the National Institute for Health...

After Lupin Deal Teva Holds Another Austedo Rival To 2033

Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the...

Time Congress Acts As Drug Launch Prices Go Up 20% Annually

As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly...

Alnylam Gives Findings of siRNA Delivery Outside of Liver

Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver. The RNA specialist detailed...

Merck Sees 80 Plus Cancer Patents By 2028 Led By Keytruda

Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants to consolidate its supremacy...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...